Watchlist Price Alert

CERo Therapeutics Inc. (CERO)

NASDAQ: CERO · Real-Time Price · USD

0.43

-0.02 (-4.44%)

At close: Jun 05, 2025, 3:59 PM

0.43

1.79%

Pre-market: Jun 06, 2025, 06:09 AM EDT

CERo Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-7.29M	-2.54K	-667.74K	-315.55K
Depreciation & Amortization	1.16M	1.12M	1.07M	735.47K
Stock-Based Compensation	96.9K	n/a	381.07K	287.74K
Other Working Capital	1.58M	-740.46K	2.41M	-365.08K
Other Non-Cash Items	239.31K	-254.61K	-2.84M	-16.48K
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	1.84M	540.11K	2.41M	-365.08K
Operating Cash Flow	-5.79M	-5.79M	-1.09M	-697.11K
Capital Expenditures	-1	-3	-694.23K	-612.57K
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	-14.34M	-325K	-178.5M
Sales Maturities Of Investments	n/a	5.64M	n/a	n/a
Other Investing Acitivies	n/a	8.69M	181.16M	-306K
Investing Cash Flow	n/a	-7.94K	180.84M	-178.5M
Debt Repayment	-14.18K	564.04K	650K	n/a
Common Stock Repurchased	n/a	-33.48K	-139.35M	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	571.68K	-33.55K	-139.21M	60.26K
Financial Cash Flow	571.68K	571.68K	-138.7M	180.3M
Net Cash Flow	-5.22M	-5.22M	41.04M	-28.77M
Free Cash Flow	-5.79M	-5.79M	-1.79M	-1.31M